Abstract
The descending-pain modulating circuit controls the experience of pain by modulating transmission of sensory signals through the dorsal horn. This circuit’s key output node, the rostral ventromedial medulla (RVM), integrates “top-down” and “bottom-up” inputs that regulate functionally defined RVM cell types, “OFF-cells” and “ON-cells,” which respectively suppress or facilitate pain-related sensory processing. While recent advances have sought molecular definition of RVM cell types, conflicting behavioral findings highlight challenges involved in aligning functional and molecularly defined types. This review summarizes current understanding, derived primarily from rodent studies but with corroborating evidence from human imaging, of the role of RVM populations in pain modulation and persistent pain states, and explores recent advances outlining inputs to, and outputs from, RVM pain-modulating neurons.
Keywords: pain, descending control, rostral ventromedial medulla, brainstem, periaqueductal gray, population dynamics
Descending control of pain in behavioral context
Nociception, the sensory processing of tissue damage, and pain, the sensory experience and suffering usually associated with tissue damage, are crucial for survival (see Glossary). While organisms can survive without sight, hearing, or olfaction, and have even regressively evolved to abandon these senses, all animal species possess nociceptors and the ability to sense injury [1-3]. Failure of the nociceptive system to detect damaging or potentially damaging somatic inputs can result in serious injury [4]. However, nociception and pain can be dissociated in that pain is not a direct function of tissue damage: tissue damage does not invariably lead to pain, and conversely, pain does not always reflect tissue damage.
The disparity between tissue damage and pain is due in large part to the actions of an intrinsic pain-modulating system that can suppress or amplify nociception and pain, and does so depending upon other biological needs and competing behavioral priorities [5-9]. The output node of this pain-modulating system is the rostral ventromedial medulla (RVM), which comprises the nucleus raphe magnus and adjacent reticular formation at the level of the facial nucleus. The RVM sends a diffuse projection to the trigeminal and spinal dorsal horns, where it interfaces with nociceptive transmission circuits (Fig. 1). The RVM integrates “bottom-up” (nociceptive sensory input) with “top-down” influences, notably from the midbrain periaqueductal gray (PAG) and medial prefrontal cortex (mPFC). Bottom-up influences support feedback control of nociceptive processing, while top-down inputs provide a potential substrate for modulation of pain by cognitive and emotional factors [10].
Fig. 1. The RVM integrates “bottom-up” sensory input with “top-down” influences.
Nociceptive information (such as thermal or mechanical noxious stimulation) is conveyed into the dorsal horn via primary sensory neurons (black), which connect to second-order neurons that relay this information to supraspinal structures, including the RVM (red, “Bottom-up”). Other dorsal horn outputs include projections to the parabrachial complex, thalamus, hypothalamus, and amygdala for further sensory processing (red dotted line). “Top-down” influences on the RVM pain-modulating circuits are schematized in blue. The best-studied top-down influence on the RVM is from the PAG, which receives cortical input from the mPFC. The RVM itself receives a number of direct inputs from higher structures including hypothalamus, preoptic area, central nucleus of the amygdala, and cortex [104]. The RVM integrates this “bottom-up” and “top-down” information, and then projects diffusely to the dorsal horn, where it facilitates or inhibits the ascending transmission of nociceptive information, forming a recurrent circuit. RVM; rostral ventromedial medulla, PAG; periaqueductal gray, mPFC; medial prefrontal cortex.
Here we briefly review the properties of pain-modulating neurons in the RVM and consider recent findings that refine current understanding of its output targets in the dorsal horn. We then discuss some inputs that can recruit pain-modulating neurons to suppress or enhance pain. Literature from rodent studies (primarily rats, but also mice) is considered, with corroborating evidence derived from human imaging.
Neural basis for pain modulation from the RVM
The RVM was originally described as an “analgesia center” following demonstrations that low-intensity (< 10 μA) electrical stimulation in this region produced potent antinociception and that opioids exerted their analgesic effects in part via an action in the RVM [11]. However, the functions of the RVM were subsequently shown to be significantly more complex. Contrary to that initial conceptual framework, the RVM not only inhibits pain but can also facilitate it, promoting hyperalgesia [5, 7, 12]. Moreover, the RVM is also implicated in autonomic function [13-15]. However, pain modulation by the RVM can be dissociated from autonomic control [16-18], suggesting that the different functions of the RVM are mediated by distinct cell populations. It is therefore imperative to identify the specific RVM cell types that mediate descending control of pain.
Functional cell classes.
Functional cell types, defined by changes in activity associated with behavioral responses to noxious stimuli, have provided a productive and coherent explanatory framework for understanding the functions of the RVM. Two cell types, “ON-cells” and “OFF-cells,” exhibit abrupt state changes associated with nocifensive withdrawal: ON-cells enter a period of activity (“burst”), and OFF-cells a period of silence (“pause”) beginning just before the execution of nocifensor reflexes, such as the tail flick or paw withdrawal evoked by heat or mechanical stimulation (Fig. 2) [19-22]. At least some cells of both classes project to the dorsal horn [23, 24]. Single- and dual-electrode recordings indicate that cells within the OFF- and ON-cell classes fire in phase, and conversely, that cells of the two classes fire out of phase, such that activity in the OFF- and ON-cell populations is reciprocal (Fig. 3) [25, 26]. This reciprocal pattern is observed even in the absence of any noxious stimulation that would entrain activity in these neurons.
Fig. 2. RVM functional cell types are defined by changes in firing associated with withdrawal from a noxious stimulus.
Representative recordings show Individual spikes emitted by an ON-cell (red) and an OFF-cell (blue) recorded simultaneously during application of noxious heat to the left hindpaw (top) and of a von Frey probe (100 g) to the right hindpaw (lower). Withdrawal is seen as deflections in the electromyogram (EMG) signal. Noxious Heat: OFF-cell stops firing (“pauses”), while the ON-cell starts to fire (“bursts”) just prior to onset of the withdrawal. Punctate Pressure: As with the heat-evoked withdrawal, the OFF-cell pauses and ON-cell bursts immediately prior to the withdrawal from the von Frey probe. In both cases, the ON-cell burst was initiated immediately after the OFF-cell ceased firing. Heat stimulus (ramped from a hold temperature of 35 °C to a maximum of 53 °C at 1.5 °C/s) was delivered using contact Peltier device. The time of von Frey fiber application is indicated by a bracket below the trace. EMG trace was rectified and smoothed to show the magnitude and timing of the withdrawal. Recording was in a lightly anesthetized rat. Adapted with permission from [21].
Fig. 3. Firing of ON- and OFF-cells is reciprocal and coordinated.
(A) Spontaneous firing of two ON-cells recorded simultaneously illustrates in-phase activity within this class. (B) Firing of an OFF-cell and ON-cell recorded simultaneously illustrates out-of-phase activity of the two cell classes: spontaneous active periods exhibited by the OFF-cell coincide with periods of lower or no activity of the ON-cell. The individual neurons were recorded simultaneously on two electrodes placed into the RVM of a lightly anesthetized rat. Ratemeter histograms show firing rates over time with 1 s bins. Adapted with permission from [25].
OFF-cells are responsible for the analgesic effects of manipulating the RVM, whereas ON-cells mediate the pro-nociceptive actions of this region (see [6, 7, 11, 27] for comprehensive reviews). Experimental activation of OFF-cells produces analgesia, and it has been calculated that direct recruitment of fewer than 100 OFF-cells is sufficient to inhibit nociception. By contrast, selective activation of ON-cells enhances nociceptive sensitivity [20, 28], and ON-cells have been shown to contribute to behavioral hypersensitivity in a number of rodent models of acute and chronic pain states [5, 12, 29, 30]. Moreover, nociceptive withdrawal threshold is measurably lower during phases when ON-cells are active and OFF-cells inactive [26].
The validity of the OFF/ON-cell categorization for classifying RVM neurons is further confirmed by the distinct pharmacological profiles exhibited by these two cell classes [20, 28, 31-41]. For example, opioids directly suppress the firing of ON-cells, with no direct effect on OFF-cells. Although OFF-cells are activated when opioids are given in a fashion that produces antinociception, this activation is indirect, via disinhibition [31, 42].
Multiple lines of evidence indicate that the OFF/ON categorization reflects a stable and generalizable property of RVM pain-modulating neurons. OFF- and ON-cells have been described in unanesthetized animals [43-45], and in mouse as well as rat [46]. These cell classes are robust to stimulus modality and stimulation site (Fig. 2). Early reports that OFF- or ON-cells responded specifically to stimulation of select body parts [47, 48] suffered from technical limitations including repeated noxious stimulation of undefined intensity, lack of a behavioral correlate, and fluctuating anesthetic levels. Moreover, conclusions derived from electrophysiological studies using the OFF/ON framework have repeatedly been found to be congruent with behavioral observations by multiple groups in awake rats and mice [9, 49-59], and with functional imaging evidence in humans [60-63].
RVM neurons that display no changes in firing to noxious stimulation are considered a third class, “NEUTRAL-cells.” In contrast with the clear understanding of OFF- and ON-cell functions, the role of NEUTRAL-cells remains largely a mystery. Like OFF- and ON-cells, at least some NEUTRAL-cells project to the spinal cord, although it is not clear that the dorsal horn is a specific target. It seems likely that NEUTRAL-cells are functionally heterogeneous, and contribute to other known functions of the RVM, such as thermogenesis [13].
Serotonergic neurons, comprising ~20% of RVM neurons, have been considered either a subclass of NEUTRAL-cells, or a distinct fourth class [64]. Serotonergic neurons do not appear to be a subset of either OFF- or ON-cells, although some serotonergic neurons are weakly responsive to noxious stimuli [64-67]. Interestingly, early studies of the RVM as a pain-modulating system focused on serotonin as a molecular marker for analgesia-producing neurons in this region, primarily because the analgesic effects of stimulating the RVM were substantially attenuated or blocked by spinal administration of serotonin antagonists [68]. However, this straightforward and attractive concept lost its appeal when it was subsequently demonstrated that spinal administration of serotonin antagonists could similarly interfere with hyperalgesia in a range of persistent pain states. Further, selective activation of serotonergic neurons in the RVM can exacerbate or induce hyperalgesia [69-71], and serotonin levels at the trigeminal dorsal horn are tonically increased in mice subjected to a painful nerve injury [72].
Reconciling these disparate findings, it is now recognized that serotonergic outflow from the RVM has both pro-nociceptive and antinociceptive effects through an action in the dorsal horn, with the former mediated by the 5HT3 receptor [73]. The variety of serotonin receptor subtypes and distinct anatomical targets in the dorsal horn may be relevant: medial RVM serotonergic neurons project more densely to the deeper laminae of the dorsal horn (laminae V through VI) and chemogenetic activation of midline serotonergic neurons produced mechanical (but not thermal) hyperalgesia, whereas lateral serotonergic RVM neurons project densely to superficial dorsal horn (laminae I and II) and chemogenetic activation of these more lateral neurons leads to thermal (but not mechanical) hyperalgesia [74, 75]. One possible resolution of these apparent discrepancies may be that serotonin acts as a modulator, enabling the functional effects of both OFF- and ON-cells at various sites under relevant conditions [76]. Mapping molecular markers to function?
The OFF/ON/NEUTRAL-cell functional classes defined using a combination of in vivo electrophysiology, behavior, and pharmacology have not so far been successfully mapped to molecular cell-types defined by neurotransmitter content, e.g., GABA or glutamate. Indeed, none of these classes has a homogeneous molecular signature. A majority of spinally projecting OFF-cells were found to be GABAergic, but so were the majority of spinally projecting ON-cells and NEUTRAL-cells [77], and a substantial proportion of each class was glutamatergic. Consistent with the fact that GABA is found in both OFF- and ON-cells, activation of RVM GABAergic neurons in the RVM using genetic tools has resulted in both pro-nociceptive [9, 54] and antinociceptive [55] effects in different experimental paradigms and rodent models. Indeed, it was clear as early as the mid-1980’s that “no one neurotransmitter” mediates the different functional outputs from the RVM [78]. In addition to GABA, glutamate, and serotonin, there are a number of neuropeptides, including Substance P, somatostatin, enkephalin, cholecystokinin, and vasoactive intestinal peptide co-localize with classical neurotransmitters in RVM neurons projecting to the dorsal horn [79, 80]. Glycine is also found in the RVM, including in projection neurons, and appears to be co-localized with GABA in many cases [81, 82]. Cholinergic neurons projecting to the dorsal horn have also been identified in the RVM [79, 83].
Another approach to defining molecular classes is to take advantage of the distinct pharmacological responses of different functional classes, which relates to their distinct receptor types. The mu-opioid receptor (MOR) is expressed only on ON-cells, and this cell class is the only one that expresses the MOR; further, all ON-cells respond to mu-opioid agonists [84]. Tools that take advantage of mu-opioid pharmacology, such as dermorphin-saporin, a neurotoxin selectively taken up by MOR-expressing neurons, have therefore been useful in confirming the pro-nociceptive function of ON-cells [53]. The G protein-coupled estrogen receptor (GPER) is another target linked specifically to ON-cells, although only a subset (~20% of ON-cells defined by MOR expression) also express GPER. Exogeneous estrogen or a GPER ligand applied directly within the RVM produces hyperalgesia, as does selective activation of GPER-expressing neurons. Conversely, local administration of a GPER receptor antagonist, or ablation of GPER-expressing neurons, reduces nociceptive responses in mice and rats [56, 85]. These findings with GPER raise the question of whether GPER-mediated activation of ON-cells is relevant to sex differences in pain or persistent pain. However, behavioral effects of GPER antagonism were seen in male as well as female mice and rats [56], which would argue against a sex-specific function of this receptor in the RVM.
Expression of the kappa opioid receptor (KOR) has also been proposed as a way to isolate the antinociceptive function of the RVM, and indeed, activation of KOR-expressing neurons in the RVM has been reported to have antinociceptive effects [58]. However, as with neurotransmitter content, KOR expression does not define a single functional population, since the majority of both OFF- and NEUTRAL-cells, as well as a small proportion of ON-cells express KOR [77]. The net antinociceptive effect of activating KOR-expressing neurons in the RVM therefore reflects the known behavioral potency of OFF-cells, which supersedes any behavioral effect of co-activating ON-cells and NEUTRAL-cells [42, 86]. Therefore, we would argue KOR-expressing cells do not represent a functionally meaningful cell type.
More broadly, these analyses of RVM functions highlight some potential pitfalls involved in interpreting behavioral experiments based on candidate molecular markers. First, when a cell population expressing a specific marker is manipulated, it is possible that only a subset of that population is responsible for any measured behavioral effect. Without independent demonstration that neurons expressing the marker are functionally homogeneous, it can only be concluded that some unknown subset of that “type” is sufficient to elicit the behavior. Indeed, this experimental paradigm does not preclude the possibility that some subset of neurons expressing the relevant marker has no effect, different effects, or even opposing effects, since other outputs might be overridden and not manifest in behavior. A further concern is that a role in other behaviors or physiological parameters that were not fully explored in the experimental paradigm cannot be ruled out. Finally, the possibility that additional cell populations defined by different, nonoverlapping, markers might also have the same net behavioral effect should be considered.
The RVM and persistent pain states
The RVM is increasingly recognized as a dynamic system, with well-documented alterations in physiology and function in a range of chronic pain models [87]. Changes in activity and responsiveness of OFF- and ON-cells develop over the course of a few hours to many days, and this plasticity likely reflects a combination of alterations in sensory input, intrinsic membrane properties, synaptic plasticity, and top-down regulation. Understanding how this shift in RVM function occurs is critical for understanding chronic pain, since there is mounting evidence that dysfunction in descending control, with loss of descending inhibition and/or an increase in descending facilitation, contributes to chronic pain in both animal models and patients [5, 7, 10, 87].
The role of the RVM in recovery from injury and associated resolution of pain is also receiving increasing interest. Pain behaviors typically resolve as tissue heals, but there is evidence that an apparent return to normal can mask a state of heightened sensitivity, referred to as “latent sensitization” [71, 88]. This heightened sensitivity can be revealed, for example, by exposure to a mild stressor [89], which is intriguing given that mild stress can activate ON-cells and suppress OFF-cell firing to produce measurable hyperalgesia [17]. One proposed mechanism for latent sensitization involves constitutive activation of MOR in the RVM, resulting in a net antinociceptive “tone” [71] that masks presumed ongoing hyperresponsiveness in nociceptive transmission circuits.
Outputs from the RVM: modulating pain transmission through descending control
RVM OFF- and ON-cells exert their effects on nociception and pain primarily via descending projections to the dorsal horn [24, 90-92], where they respectively inhibit and facilitate the transmission of signals relevant to both local processing (e.g., nocifensor reflexes) and the sensory experience of pain, including the affective dimension [93-95]. RVM terminals relevant to pain-modulation are concentrated in the superficial dorsal horn (laminae I/II), the neck of the dorsal horn (laminae IV/V) and surrounding the central canal (lamina X), and primarily contact somata and dendrites, rather than primary afferent terminals [96, 97]. Projections are diffuse, terminating bilaterally and at multiple levels [55, 75, 91]. Moreover, dorsal horn neurons responding to RVM input are heterogeneous in terms of location, morphology, and firing pattern [98, 99]. There is also preliminary evidence that the RVM can modulate other descending systems, such as the noradrenergic outputs of the locus coeruleus[100].
The diffuse nature of the RVM spinal projection, together with its multiple dorsal horn targets, implies that the RVM has the capacity to modulate nociceptive processing at multiple “touch points” in the dorsal horn, each of which merits detailed investigation. One recent focus has been on the targets of GABAergic RVM projection neurons. As already noted, up to about half of the RVM neurons projecting to the dorsal horn are GABAergic [82]. Consistent with the fact that a substantial proportion of both OFF- and ON-cells is GABAergic [77], RVM GABAergic neurons exert both pro-nociceptive and antinociceptive effects, likely mediated by subsets of ON-cells and OFF-cells, respectively. Thus, chemogenetic or optogenetic activation of RVM GABAergic neurons projecting to the dorsal horn or their terminals was reported to enhance mechanical nociception in both mice and rats, an effect attributed to RVM GABA-mediated inhibition of inhibitory interneurons in the dorsal horn [9, 54]. By contrast, selective activation of RVM inhibitory neurons (GABA and/or enkephalin) connecting with primary afferent terminals in the dorsal horn was found to induce mechanical and thermal hypoalgesia in mice [55]. Thus, the RVM-mediated inhibition of inhibitory interneurons was found to enhance nociception, whereas the RVM-mediated inhibition of transmission from primary afferents suppressed nociception. It is notable that manipulation of GABA-expressing RVM outputs with specific, distinct targets in the dorsal horn has opposing behavioral effects. Indeed, this work highlights the importance of considering connectivity in defining and implementing the functions of RVM neurons, beyond characterization of the neurons’ responses to noxious stimuli or molecular content (see Outstanding Questions).
Outstanding questions.
Neuronal cell “types” can be defined by their physiology/function, connectivity, and/or by molecular content. In RVM, neurons are heterogenous in terms of both physiology and molecular markers, and molecular cell populations do not map to functionally defined cell types. However, four decades of research demonstrates that RVM OFF- and ON-cell classes are robust and functionally relevant. Can molecular data be integrated with physiological evidence to better define cell types in RVM? Can functionally relevant cell types ultimately be manipulated and targeted for treatment of persistent pain states?
RVM outputs to specific targets in the dorsal horn have opposing behavioral effects. How does the RVM interface with intrinsic circuits in the dorsal horn, and is it possible to take advantage of specific outputs to provide pain treatment?
Parallel pathways convey nociceptive information to RVM. Why do multiple streams of information exist and what are their roles? Do separate pathways convey unique information, or are they redundant? Is information in the different pathways integrated to produce complete behavioral responses? How do different pathways contribute to persistent pain states?
Top-down inputs into the pain-modulating system constantly weigh various factors, such as intensity, context, and emotional state, to regulate the pain experience. How do top-down inputs adapt over time and contribute to the development of persistent pain states? How do variations in top-down inputs across individuals contribute to unique pain responses?
Behavioral responses require coordinated activity across neuronal populations. Although activity of physiologically defined RVM cell types shows evidence of coordination, there is little evidence for local interaction within or between these cell types. How do the reciprocal firing patterns of ON- and OFF-cells contribute to pain modulation, and what intrinsic connections or inputs regulate activity within and between these cell types?
Inputs to RVM pain-modulating neurons
As described above, the net functional roles of RVM OFF- and ON-cells are now well established, and their primary output, to the dorsal horn, is being delineated in increasing detail. With that foundation, defining the inputs to these neurons -- understanding the parameters that influence their activity -- should provide insights into how intrinsic and extrinsic factors that can influence pain exert effects on the RVM. Factors known to influence RVM OFF- and ON-cell firing include noxious sensory information, circuits mediating opioid analgesia [101], autonomic status [15], environmental light levels [102], and stress leading to both stress-induced analgesia and hyperalgesia [17, 103]. Functional pathways through which this information is conveyed to the RVM are not yet well defined, but anatomical tracing studies have revealed numerous inputs to the RVM from across the neuraxis, including the dorsal horn and higher structures such as midbrain periaqueductal gray (PAG), hypothalamus, anterior cingulate, and amygdala [6, 104]. Although anatomical studies by themselves do not reveal whether a particular input is relevant to the pain-modulating function of the RVM, several circuits are well defined, and will be considered here.
“Bottom up” inputs convey nociceptive information to RVM pain-modulating neurons
ON-cells are activated by noxious stimuli, whilst OFF-cell firing is suppressed. This acute, pain-related activation of pain-facilitating ON-cells and suppression of pain-inhibiting OFF-cells functions as a positive feedback loop, facilitating responses to subsequent sensory inputs [105]. Functional pathways through which nociceptive information gains access to RVM ON- and OFF-cells are only now being defined, but it has become clear that there are at least two parallel pathways that convey nociceptive information to the RVM (Fig. 4).
Fig. 4. The RVM receives two parallel information streams from the dorsal horn with different temporal properties.
Left: The schematic illustrates indirect input to the RVM from the dorsal horn, via a relay in the parabrachial complex [153] (blue), and a parallel, direct projection from the dorsal horn (specifically the trigeminal dorsal horn [116], red). Right: Firing rate histograms show representative responses of OFF-cells and ON-cells to optogenetic activation of dorsal horn terminals in the PB (indirect pathway) and in the RVM itself (direct pathway, stimulation sites shown in schematic at left). Blue overlay indicates periods of light delivery (30 s). The response to activation of the indirect pathway through the PB evokes a delayed response in the RVM that outlasts the stimulus, whereas the response to activation of the direct pathway is time-locked to light delivery. Recording in lightly anesthetized rat, histogram bins 1 s. Light delivered to trigeminal dorsal horn terminals in the PB (indirect pathway) and the RVM (direct pathway). PB: parabrachial complex; RVM: rostral ventromedial medulla, sp/s: spikes/s. Adapted with permission from [116].
One pathway is an indirect pathway with a relay in the parabrachial complex (PB). The PB is a major nociceptive, emotional, and autonomic processing and relay center that at least in rodents is the target of the bulk of supraspinal projections from the superficial dorsal horn [106-108]. It also receives input from deep dorsal horn [109, 110]. The PB projects directly to the RVM [111-113], and optogenetic inhibition of the PB terminals in the RVM demonstrates that a PB relay contributes to the OFF-cell pause and ON-cell burst [112]. This system demonstrates considerable plasticity in persistent inflammatory pain states [114]. There is also a direct pathway to the RVM from the dorsal horn [82, 115-117], and recent optogenetic studies have shown that this direct input also contributes to nociceptive responses of OFF- and ON-cells [116]. Direct GABAergic input to OFF-cells from the dorsal horn may contribute to the characteristic pause that defines these neurons, since it is known that this pause is mediated by GABA, and that the relevant input is not a local interneuron [116, 118-120].
It is reasonable to assume that the direct and indirect nociceptive pathways are not mutually exclusive. Indeed, some neurons in the trigeminal complex project to both the RVM and the PB. However, the RVM response to activation of the two pathways is not identical, with selective activation of the indirect pathway producing a prolonged neuronal response in the RVM compared to that elicited by activation of the direct pathway [116] (Fig. 4). This raises the possibility that these parallel input pathways play distinct functional roles and contribute to the complexity of modulating both acute and chronic pain (see Outstanding Questions).
“Top down” inputs to the RVM
“Top-down” inputs to the RVM provide a potential substrate through which cognitive and emotional factors can influence pain [10]. The most prominent input to the RVM from higher structures arises from the PAG, which also relays information from cortical regions and amygdala to the RVM. The influence of the PAG on RVM, and how the PAG is recruited by medial prefrontal cortex (mPFC) will be considered here.
Midbrain periaqueductal gray
Like the RVM, the PAG is a heterogeneous brain region with multiple functions, but it plays a prominent role in pain, stress, and defensive behavior [121-123]. As with the RVM, electrical stimulation or focal injection of mu-opioid agonists in the PAG produces antinociception. Importantly, electrical stimulation has been used clinically for pain relief, confirming that this system modulates pain processing, and is not simply suppressing motor output [124]. Antinociception produced by activation of the PAG is mediated by the RVM, via the latter’s descending output to the dorsal horn [6]. Electrical stimulation of the circuit elicits analgesia in humans [124-126], just as it does in rats [127, 128]. Although the pain-modulating functions of the PAG have been studied most intensively in the context of analgesia, it can exert a pro-nociceptive effect [129-131].
As with the RVM itself, attempts to define molecular cell-types in the PAG have proved challenging [132]. Activation of GABAergic neurons leads to increased nociceptive behaviors [133, 134]. This is unlikely to represent a straightforward circuit, however, since anatomical studies demonstrate that the PAG neurons projecting to the RVM include both GABAergic and glutamatergic populations, and there is no consensus as to the relative densities of the two projections [135-137].
Opioid engagement of the PAG-RVM system to produce analgesia has long been explained using the “disinhibition hypothesis,” which posits that opioids act presynaptically to inhibit GABA release onto the PAG output neurons projecting to the RVM [101, 138]. This certainly occurs, but it is also becoming clear that the disinhibition hypothesis is not a complete explanation of the link between the PAG and the RVM. Opioids can inhibit PAG neurons post-synaptically via activation of G protein-coupled inwardly rectifying potassium (GIRK) channels [101], and some PAG-RVM output neurons express mu opioid receptors [139, 140], suggesting that direct inhibitory effects of opioids in the PAG are also important. Moreover, MOR expressed by both GABAergic and glutamatergic PAG populations has been implicated in different forms of stress-induced analgesia [141]. These latter data suggest that there are at least two parallel opioid-sensitive outputs from the PAG to the RVM.
The PAG relays the influence of the mPFC on nociception
The PAG receives a major cortical input from the mPFC, and there is accumulating evidence that dysfunction of this circuit underlies diminished descending control in chronic pain states, particularly neuropathic pain models. Stimulation of mPFC produces analgesia under basal conditions, but more important, inhibition of mPFC neurons projecting to the PAG has an effect by itself, and results in hyperalgesia in rats [142, 143]. This suggests that mPFC maintains a tonic anti-nociceptive influence via the PAG, and raises the possibility that loss of this tonic influence contributes to chronic pain states. Consistent with this latter idea, excitability of mPFC neurons projecting to the PAG is reduced after nerve injury, a change due at least in part to alteration in the balance of inhibitory and excitatory drive from the basolateral amygdala, as well as changes in endocannabinoid function in mPFC [144-147]. Confirmation that mPFC engages descending control comes from the observation that activation of mPFC depresses noxious-evoked responses of dorsal horn neurons [143].
It is worth noting that not all cortical influences on pain are mediated by engaging descending control. Manipulations of anterior cingulate cortex (ACC) can alter pain behaviors, and even activity of nociceptive dorsal horn neurons [148]. Like the mPFC, the ACC sends a substantial projection to the PAG. However, opioids applied directly in the ACC do not alter pain behaviors in rats subjected to nerve injury, although this procedure does induce a conditioned place preference (CPP) in these animals (and not in controls that are not experiencing neuropathic pain) [95, 148]. By contrast, opioids applied in the RVM not only produce a CPP, but also attenuate pain behaviors in rats [95, 149]. These findings imply that ACC plays a role in the affective dimension of pain after nerve injury, but that unlike mPFC, it does not recruit the RVM to modulate activity at the level of the dorsal horn.
RVM Population Dynamics and Implications for Pain Modulation
The foundational data defining the physiology and function of RVM neurons have for the most part come from studies of single, functionally characterized neurons. This approach has provided insights into how information is processed in the RVM, and how and when pain-modulating neurons are recruited to exert their effects. However, codes implemented at the level of a neuronal population may not be evident at the level of individual neurons. This is not only because of variability when looking at individual neurons, but because variation and co-variation within and between populations may be functionally meaningful.
As noted above, single- and dual-electrode recordings show that cells within the OFF- and ON-cell classes fire in phase, and conversely, that cells of the two classes fire out of phase, such that activity in the OFF- and ON-cell populations is reciprocal (Fig. 3) [25, 26]. This implies that there are integrating mechanisms that coordinate the activity of all members within each class and that this integration is functionally significant.
Little is known, however, about synaptic connectivity within the RVM. ON-cells likely do not inhibit the OFF-cells, given that selective inhibition of ON-cells does not reduce the OFF-cell pause and that the ON-cell burst does not precede the OFF-cell pause [118, 119]. These observations imply that ON-cells, as a population, do not function as an inhibitory interneuron within the RVM. Indeed, ON-cells are thought to lack local connections with the RVM, although OFF-cells give off local collaterals in addition to their projections to the dorsal horns [150].
Understanding the integrating mechanisms that coordinate activity within and between OFF- and ON-cell classes thus remains a significant challenge. Large-scale population recordings that could bring to light relationships among neurons within and between the different functional classes, determine whether different cohorts of OFF- and ON-cells are engaged under different conditions, and reveal information contained in the dynamics of evoked and ongoing activity [151] would be a significant advance for the field (see Outstanding Questions).
Concluding remarks
Delineating the neural basis of pain remains elusive, at least in part because “pain is not simply the end product of a linear sensory transmission system; it is a dynamic process that involves continuous interactions among complex ascending and descending systems” [152]. Moreover, even in the context of actual or potential tissue damage, pain must be regulated to allow the organism to accomplish other behavioral priorities beyond facilitating tissue repair and healing. The descending pain-modulating system enables this behavioral prioritization, bidirectionally regulating sensory transmission. Dysfunction of this modulating system contributes to pathological pain states.
The output of this modulatory system, the RVM, comprises two cell classes, ON-cells and OFF-cells, which respectively facilitate and suppress nociceptive transmission. While these functional RVM cell classes based on firing properties have been extensively characterized and validated, attempt to align these functional types with molecularly defined types have been challenging, due to the heterogeneous and overlapping molecular expression profiles of ON- and OFF-cells. Nonetheless, there is increasing recognition that both top-down and bottom-up influences are integrated in the RVM to suppress or enhance pain. Further elucidation of inputs to and outputs from RVM pain-modulating neurons, individually and as coordinated populations, could point to targets for the treatment of persistent pain states.
Highlights.
The rostral ventromedial medulla (RVM) is the key output node of the descending pain-modulating system.
Intrinsic and extrinsic factors contribute to the pain experience by influencing the activity of two functional types of RVM neurons, OFF-cells and ON-cells, which respectively exert inhibitory and facilitatory control over nociceptive transmission and pain.
Dysfunction in descending control, which alters the distinct inhibitory and facilitatory outputs of RVM, contributes to persistent pain states.
Characterizing the function(s) of genetically defined RVM populations has been challenging, and conflicting results have emerged, stressing the need for rigorous interpretation of experiments based on candidate molecular markers.
Further investigation of interactions within and between functional RVM populations are a critical next step in improving our understanding of descending control of pain.
Acknowledgements
This work was supported by the National Institutes of Health Grant NS098660 (to M.M.H). C.C.D.P. was supported by the National Institute of Dental and Craniofacial Research Fellowship F31 DE030677.
Glossary
- Pain
An unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage. As a sensory experience, pain is distinct from nociception.
- Nociception
The neural process of encoding noxious stimuli. Nociception may, or may not, be associated with pain.
- Analgesia
Insensitivity to stimuli that normally produce a pain response.
- Hyperalgesia
Increased sensitivity to stimuli that normally produce a pain response.
- Hypoalgesia
Decreased sensitivity to stimuli that normally produce a pain response.
- Neuropathic pain
Pain caused by injury to or malfunction of the sensory nervous system.
- Conditioned Place Preference (CPP)
Learning measurement to test the motivational effects of a stimulus. When animals demonstrate a preference associated with a drug or experimental manipulation, it is inferred that this manipulation produced pain relief.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Declarations of interests
The authors declare no conflicts of interest.
References
- 1.Berta A. et al. (2014) Review of the cetacean nose: Form, function, and evolution. Anat Rec (Hoboken) 297, 2205–15 [DOI] [PubMed] [Google Scholar]
- 2.Niemiller ML et al. (2013) Evidence for hearing loss in amblyopsid cavefishes. Biol Lett 9, 20130104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Policarpo M. et al. (2021) Contrasting gene decay in subterranean vertebrates: Insights from cavefishes and fossorial mammals. Mol Biol Evol 38, 589–605 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Dib-Hajj SD and Waxman SG (2019) Sodium channels in human pain disorders: Genetics and pharmacogenomics. Annu Rev Neurosci 42, 87–106 [DOI] [PubMed] [Google Scholar]
- 5.Heinricher MM et al. (2009) Descending control of nociception: Specificity, recruitment and plasticity. Brain Res Rev 60, 214–225 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Heinricher MM and Fields HL (2013) Central nervous system mechanisms of pain modulation. In Wall and Melzack's textbook of pain, 6th ed. (McMahon S et al. eds), pp. 129–142, Elsevier [Google Scholar]
- 7.Heinricher MM (2016) Pain modulation and the transition from acute to chronic pain. Adv Exp Med Biol 904, 105–15 [DOI] [PubMed] [Google Scholar]
- 8.Fields H. (2004) State-dependent opioid control of pain. Nat Rev Neurosci 5, 565–75 [DOI] [PubMed] [Google Scholar]
- 9.Xue Y. et al. (2023) Dissecting neural circuits from rostral ventromedial medulla to spinal trigeminal nucleus bidirectionally modulating craniofacial mechanical sensitivity. Prog Neurobiol 232, 102561. [DOI] [PubMed] [Google Scholar]
- 10.Bushnell MC et al. (2013) Cognitive and emotional control of pain and its disruption in chronic pain. Nat Rev Neurosci 14, 502–11 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Fields HL and Heinricher MM (1985) Anatomy and physiology of a nociceptive modulatory system. Philos Trans of the R Soc Lond B Biol Sci 308, 361–374 [DOI] [PubMed] [Google Scholar]
- 12.Porreca F. et al. (2002) Chronic pain and medullary descending facilitation. Tr Neurosci 25, 319–25 [DOI] [PubMed] [Google Scholar]
- 13.Morrison SF and Nakamura K (2019) Central mechanisms for thermoregulation. Annu Rev Physiol 81, 285–308 [DOI] [PubMed] [Google Scholar]
- 14.Blessing WW (1997) The lower brainstem and bodily homeostasis, Oxford University Press [Google Scholar]
- 15.Mason P. (2005) Deconstructing endogenous pain modulations. J Neurophysiol 94, 1659–63 [DOI] [PubMed] [Google Scholar]
- 16.Rathner JA et al. (2001) Cold-activated raphe-spinal neurons in rats. J Physiol (Lond) 535, 841–854 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Martenson ME et al. (2009) A possible neural basis for stress-induced hyperalgesia. Pain 142, 236–44 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Vianna DM et al. (2008) Cardiovascular and behavioral responses to conditioned fear after medullary raphe neuronal blockade. Neuroscience 153, 1344–53 [DOI] [PubMed] [Google Scholar]
- 19.Fields HL et al. (1983) The activity of neurons in the rostral medulla of the rat during withdrawal from noxious heat. J Neurosci 3, 2545–2552 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Heinricher MM and Neubert MJ (2004) Neural basis for the hyperalgesic action of cholecystokinin in the rostral ventromedial medulla. J Neurophysiol 92, 1982–9 [DOI] [PubMed] [Google Scholar]
- 21.Carlson JD et al. (2007) Sensitization of pain-modulating neurons in the rostral ventromedial medulla after peripheral nerve injury. J Neurosci 27, 13222–31 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Tang JS et al. (2021) Responses of neurons in rostral ventromedial medulla to nociceptive stimulation of craniofacial region and tail in rats. Brain Res 1767, 147539. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Vanegas H. et al. (1984) Tail-flick related activity in medullospinal neurons. Brain Res 321, 135–41 [DOI] [PubMed] [Google Scholar]
- 24.Fields HL et al. (1995) Dorsal horn projection targets of ON and OFF cells in the rostral ventromedial medulla. J Neurophysiol 74, 1742–59 [DOI] [PubMed] [Google Scholar]
- 25.Barbaro NM et al. (1989) Putative nociceptive modulatory neurons in the rostral ventromedial medulla of the rat display highly correlated firing patterns. Somatosens Mot Res 6, 413–25 [DOI] [PubMed] [Google Scholar]
- 26.Heinricher MM et al. (1989) Putative nociceptive modulating neurons in the rostral ventromedial medulla of the rat: Firing of on- and off-cells is related to nociceptive responsiveness. Somatosens Mot Res 6, 427–39 [DOI] [PubMed] [Google Scholar]
- 27.Chen Q and Heinricher MM (2019) Descending control mechanisms and chronic pain. Curr Rheumatol Rep 21, 13. [DOI] [PubMed] [Google Scholar]
- 28.Neubert MJ et al. (2004) Nociceptive facilitating neurons in the rostral ventromedial medulla. Pain 110, 158–165 [DOI] [PubMed] [Google Scholar]
- 29.Meng ID et al. (2011) Pathophysiology of medication overuse headache: Insights and hypotheses from preclinical studies. Cephalalgia 31, 851–60 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Ossipov MH et al. (2004) Antinociceptive and nociceptive actions of opioids. J Neurobiol 61, 126–48 [DOI] [PubMed] [Google Scholar]
- 31.Heinricher MM et al. (1992) Direct and indirect actions of morphine on medullary neurons that modulate nociception. Neuroscience 48, 533–43 [DOI] [PubMed] [Google Scholar]
- 32.Heinricher MM et al. (1988) Opposing actions of norepinephrine and clonidine on single pain-modulating neurons in rostral ventromedial medulla. In Pain res clin mgt (Dubner R et al. eds), pp. 590–594, Elsevier [Google Scholar]
- 33.Meng ID et al. (1998) An analgesia circuit activated by cannabinoids. Nature 395, 381–3 [DOI] [PubMed] [Google Scholar]
- 34.Meng ID and Johansen JP (2004) Antinociception and modulation of rostral ventromedial medulla neuronal activity by local microinfusion of a cannabinoid receptor agonist. Neuroscience 124, 685–93 [DOI] [PubMed] [Google Scholar]
- 35.Selden NR et al. (2007) Purinergic actions on neurons that modulate nociception in the rostral ventromedial medulla. Neuroscience 146, 1808–16 [DOI] [PubMed] [Google Scholar]
- 36.Harasawa I. et al. (2000) Delta opioid receptor mediated actions in the rostral ventromedial medulla on tail flick latency and nociceptive modulatory neurons. Pain 85, 255–262 [DOI] [PubMed] [Google Scholar]
- 37.Meng ID et al. (2005) Kappa opioids inhibit physiologically identified medullary pain modulating neurons and reduce morphine antinociception. J Neurophysiol 93, 1138–44 [DOI] [PubMed] [Google Scholar]
- 38.Marabese I. et al. (2007) Periaqueductal gray metabotropic glutamate receptor subtype 7 and 8 mediate opposite effects on amino acid release, rostral ventromedial medulla cell activities, and thermal nociception. J Neurophysiol 98, 43–53 [DOI] [PubMed] [Google Scholar]
- 39.de Novellis V. et al. (2005) Periaqueductal grey CB1 cannabinoid and metabotropic glutamate subtype 5 receptors modulate changes in rostral ventromedial medulla neuronal activities induced by subcutaneous formalin in the rat. Neuroscience 134, 269. [DOI] [PubMed] [Google Scholar]
- 40.de Novellis V. et al. (2007) The prokineticin receptor agonist Bv8 increases GABA release in the periaqueductal grey and modifies RVM cell activities and thermoceptive reflexes in the rat. Eur J Neurosci 26, 3068–78 [DOI] [PubMed] [Google Scholar]
- 41.Hryciw G. et al. (2021) Physiological properties of pain-modulating neurons in rostral ventromedial medulla in female rats, and responses to opioid administration. Neurobiol Pain 10, 100075. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Heinricher MM et al. (1994) Disinhibition of off-cells and antinociception produced by an opioid action within the rostral ventromedial medulla. Neuroscience 63, 279–288 [DOI] [PubMed] [Google Scholar]
- 43.McGaraughty S. et al. (1993) Two distinct unit activity responses to morphine in the rostral ventromedial medulla of awake rats. Brain Res 604, 331–3 [DOI] [PubMed] [Google Scholar]
- 44.Clarke RW et al. (1994) Identification of nocifensor reflex-related neurons in the rostroventromedial medulla of decerebrated rats. Brain Res 636, 169–74 [DOI] [PubMed] [Google Scholar]
- 45.Foo H and Mason P (2005) Movement-related discharge of ventromedial medullary neurons. J Neurophysiol 93, 873–83 [DOI] [PubMed] [Google Scholar]
- 46.Hellman KM et al. (2007) Activity of murine raphe magnus cells predicts tachypnea and on-going nociceptive responsiveness. J Neurophysiol 98, 3121–3133 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Ellrich J. et al. (2000) Are 'neutral cells' in the rostral ventro-medial medulla subtypes of on- and off-cells? Neurosci Res 38, 419–423. [DOI] [PubMed] [Google Scholar]
- 48.Ellrich J. et al. (2001) Is the response pattern of on- and off-cells in the rostral ventromedial medulla to noxious stimulation independent of stimulation site? Exp Brain Res 136, 394–9. [DOI] [PubMed] [Google Scholar]
- 49.Hurley RW and Hammond DL (2000) The analgesic effects of supraspinal μ and δ opioid receptor agonists are potentiated during persistent inflammation. J Neurosci 20, 1249–59 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Smith DJ et al. (1997) Dose-dependent pain-facilitatory and -inhibitory actions of neurotensin are revealed by SR 48692, a nonpeptide neurotensin antagonist: Influence on the antinociceptive effect of morphine. J Pharmacol Exp Ther 282, 899–908 [PubMed] [Google Scholar]
- 51.Kovelowski CJ et al. (2000) Supraspinal cholecystokinin may drive tonic descending facilitation mechanisms to maintain neuropathic pain in the rat. Pain 87, 265–273 [DOI] [PubMed] [Google Scholar]
- 52.Edelmayer RM et al. (2009) Medullary pain facilitating neurons mediate allodynia in headache-related pain. Ann Neurol 65, 184–93 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Porreca F. et al. (2001) Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the μ-opioid receptor. J Neurosci 21, 5281–8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Francois A. et al. (2017) A brainstem-spinal cord inhibitory circuit for mechanical pain modulation by GABA and enkephalins. Neuron 93, 822–839.e6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Zhang Y. et al. (2015) Identifying local and descending inputs for primary sensory neurons. J Clin Invest 125, 3782–94 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Jiao Y. et al. (2023) Molecular identification of bulbospinal ON neurons by GPER, which drives pain and morphine tolerance. J Clin Invest 133, e154588. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Kim JH et al. (2018) Yin-and-yang bifurcation of opioidergic circuits for descending analgesia at the midbrain of the mouse. Proc Natl Acad Sci USA 115, 11078–11083 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Nguyen E. et al. (2022) Medullary kappa-opioid receptor neurons inhibit pain and itch through a descending circuit. Brain 145, 2586–2601 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Nguyen E. et al. (2023) Cell type-specific dissection of sensory pathways involved in descending modulation. Trends Neurosci, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Oliva V. et al. (2022) Simultaneous brain, brainstem, and spinal cord pharmacological-fMRI reveals involvement of an endogenous opioid network in attentional analgesia. eLife 11, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Brooks JC et al. (2017) Resolving the brainstem contributions to attentional analgesia. J Neurosci 37, 2279–2291 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Mills EP et al. (2018) Brainstem pain-control circuitry connectivity in chronic neuropathic pain. J Neurosci 38, 465–473 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Mills EP et al. (2021) Brainstem pain-modulation circuitry and its plasticity in neuropathic pain: Insights from human brain imaging investigations. Front Pain Res 2, 705345. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Gao K and Mason P (2000) Serotonergic raphe magnus cells that respond to noxious tail heat are not ON or OFF cells. J Neurophysiol 84, 1719–25 [DOI] [PubMed] [Google Scholar]
- 65.Gao K. et al. (1997) Serotonergic pontomedullary neurons are not activated by antinociceptive stimulation in the periaqueductal gray. J Neurosci 17, 3285–92 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Gao K. et al. (1998) Activation of serotonergic neurons in the raphe magnus is not necessary for morphine analgesia. J Neurosci 18, 1860–8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Gau R. et al. (2012) Noxious stimulation excites serotonergic neurons: A comparison between the lateral paragigantocellular reticular and the raphe magnus nuclei. Pain 154, 647–659 [DOI] [PubMed] [Google Scholar]
- 68.LeBars D. (1988) Serotonin and pain. In Neuronal serotonin (Osborne NN and Hamond M eds), pp. 171–226, Wiley [Google Scholar]
- 69.Cai YQ et al. (2014) Optogenetic activation of brainstem serotonergic neurons induces persistent pain sensitization. Mol Pain 10, 70. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Mo SY et al. (2023) Descending serotonergic modulation from rostral ventromedial medulla to spinal trigeminal nucleus is involved in experimental occlusal interference-induced chronic orofacial hyperalgesia. J Headache Pain 24, 50. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Cooper AH et al. (2022) Postsurgical latent pain sensitization is driven by descending serotonergic facilitation and masked by μ-opioid receptor constitutive activity in the rostral ventromedial medulla. J Neurosci 42, 5870–5881 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Cramer N. et al. (2023) Elevated serotonin in mouse spinal dorsal horn is pronociceptive. eNeuro 10, ENEURO.0293-23.202 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Suzuki R. et al. (2004) Bad news from the brain: Descending 5-HT pathways that control spinal pain processing. Trends Pharmacol Sci 25, 613–617 [DOI] [PubMed] [Google Scholar]
- 74.Gautier A. et al. (2017) Differential innervation of superficial versus deep laminae of the dorsal horn by bulbo-spinal serotonergic pathways in the rat. IBRO Rep 2, 72–80 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Ganley RP et al. (2023) Targeted anatomical and functional identification of antinociceptive and pronociceptive serotonergic neurons that project to the spinal dorsal horn. Elife 12, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Heinricher MM and McGaraughty S (1999) Brainstem pain modulating neurons and behavioral state. In State-dependent processing in somatosensory pathways (Soja PJ ed), pp. 487–503, CRC Press [Google Scholar]
- 77.Winkler CW et al. (2006) Kappa opioid receptor (KOR) and GAD67 immunoreactivity are found in OFF and NEUTRAL cells in the rostral ventromedial medulla. J Neurophysiol 96, 3465–3473 [DOI] [PubMed] [Google Scholar]
- 78.Bowker RM et al. (1982) Organization of descending serotonergic projections to the spinal cord. Prog Brain Res 57, 239–65 [DOI] [PubMed] [Google Scholar]
- 79.Bowker RM et al. (1983) Descending serotonergic, peptidergic and cholinergic pathways from the raphe nuclei: A multiple transmitter complex. Brain Res 288, 33–48 [DOI] [PubMed] [Google Scholar]
- 80.Bowker RM et al. (1988) Peptidergic neurons in the nucleus raphe magnus and the nucleus gigantocellularis: Their distributions, interrelationships, and projections to the spinal cord. Progress in Brain Res 77, 95–127 [DOI] [PubMed] [Google Scholar]
- 81.Rampon C. et al. (1996) Distribution of glycine-immunoreactive cell bodies and fibers in the rat brain. Neuroscience 75, 737–55 [DOI] [PubMed] [Google Scholar]
- 82.Hossaini M. et al. (2012) Distribution of glycine/GABA neurons in the ventromedial medulla with descending spinal projections and evidence for an ascending glycine/GABA projection. PLoS ONE 7, e35293. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Holmes CJ et al. (1994) Distribution of cholinergic, GABAergic and serotonergic neurons in the medial medullary reticular formation and their projections studied by cytotoxic lesions in the cat. Neuroscience 62, 1155–78 [DOI] [PubMed] [Google Scholar]
- 84.Heinricher MM and Ingram SL (2008) The brainstem and nociceptive modulation. In The science of pain (Bushnell MC and Basbaum AI eds), pp. 593–626, Academic Press [Google Scholar]
- 85.Xu JJ et al. (2021) G protein-coupled estrogen receptor in the rostral ventromedial medulla contributes to the chronification of postoperative pain. CNS Neurosci Ther 27, 1313–1326 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Heinricher MM and Tortorici V (1994) Interference with GABA transmission in the rostral ventromedial medulla: Disinhibition of off-cells as a central mechanism in nociceptive modulation. Neuroscience 63, 533–46 [DOI] [PubMed] [Google Scholar]
- 87.Chen Q and Heinricher MM (2022) Shifting the balance: How top-down and bottom-up inputs modulate pain via the rostral ventromedial medulla. Front Pain Res 3, 932476. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Rivat C. et al. (2007) Non-nociceptive environmental stress induces hyperalgesia, not analgesia, in pain and opioid-experienced rats. Neuropsychopharmacology 32, 2217–28 [DOI] [PubMed] [Google Scholar]
- 89.Chen W. et al. (2018) Corticotropin-releasing factor in the brain and blocking spinal descending signals induce hyperalgesia in the latent sensitization model of chronic pain. Neuroscience 381, 149–158 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Skagerberg G and Björklund A (1985) Topographic principles in the spinal projections of serotonergic and non-serotonergic brainstem neurons in the rat. Neuroscience 15, 445–80 [DOI] [PubMed] [Google Scholar]
- 91.Huisman AM et al. (1981) Quantitative differences in collateralization of the descending spinal pathways from red nucleus and other brain stem cell groups in rat as demonstrated with the multiple fluorescent retrograde tracer technique. Brain Res 209, 271–86 [DOI] [PubMed] [Google Scholar]
- 92.Aicher SA et al. (2012) Descending projections from the rostral ventromedial medulla (RVM) to trigeminal and spinal dorsal horns are morphologically and neurochemically distinct. J Chem Neuroanat 43, 103–111 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.De Felice M. et al. (2011) Engagement of descending inhibition from the rostral ventromedial medulla protects against chronic neuropathic pain. Pain 152, 2701–9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Hirakawa N. et al. (2000) Bi-directional changes in affective state elicited by manipulation of medullary pain-modulatory circuitry. Neuroscience 100, 861–871 [DOI] [PubMed] [Google Scholar]
- 95.Gomtsian L. et al. (2018) Morphine effects within the rodent anterior cingulate cortex and rostral ventromedial medulla reveal separable modulation of affective and sensory qualities of acute or chronic pain. Pain 159, 2512–2521 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Antal M. et al. (1996) Direct evidence of an extensive GABAergic innervation of the spinal dorsal horn by fibres descending from the rostral ventromedial medulla. Neuroscience 73, 509–18 [DOI] [PubMed] [Google Scholar]
- 97.Light AR and Kavookjian AM (1985) The ultrastructure and synaptic connections of the spinal terminations from single, physiologically characterized axons descending in the dorsolateral funiculus from the midline, pontomedullary region. J Comp Neurol 234, 549–60 [DOI] [PubMed] [Google Scholar]
- 98.Otsu Y and Aubrey KR (2022) Kappa opioids inhibit the GABA/glycine terminals of rostral ventromedial medulla projections in the superficial dorsal horn of the spinal cord. J Physiol 600, 4187–4205 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Willis WD Jr. (1988) Anatomy and physiology of descending control of nociceptive responses of dorsal horn neurons: Comprehensive review. Prog Brain Res 77, 1–29 [DOI] [PubMed] [Google Scholar]
- 100.Lubejko ST et al. (2023) Inputs to the locus coeruleus from the periaqueductal gray and rostroventral medulla shape opioid-mediated descending pain modulation. bioRxiv, DOI: 10.1101/2023.10.10.561768 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Bagley EE and Ingram SL (2020) Endogenous opioid peptides in the descending pain modulatory circuit. Neuropharmacology 173, 108131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Martenson ME et al. (2016) A possible neural mechanism for photosensitivity in chronic pain. Pain 157, 868–878 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.McGaraughty S and Heinricher MM (2002) Microinjection of morphine into various amygdaloid nuclei differentially affects nociceptive responsiveness and RVM neuronal activity. Pain 96, 153–162 [DOI] [PubMed] [Google Scholar]
- 104.Hermann DM et al. (1997) Afferent projections to the rat nuclei raphe magnus, raphe pallidus and reticularis gigantocellularis pars alpha demonstrated by iontophoretic application of choleratoxin (subunit b). J Chem Neuroanat 13, 1–21 [DOI] [PubMed] [Google Scholar]
- 105.Ramirez F and Vanegas H (1989) Tooth pulp stimulation advances both medullary off-cell pause and tail flick. Neurosci Lett 100, 153–6 [DOI] [PubMed] [Google Scholar]
- 106.Gauriau C and Bernard JF (2002) Pain pathways and parabrachial circuits in the rat. Exp Physiol 87, 251–8. [DOI] [PubMed] [Google Scholar]
- 107.Todd AJ (2010) Neuronal circuitry for pain processing in the dorsal horn. Nat Rev Neurosci 11, 823–836 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Saito H. et al. (2017) Ascending projections of nociceptive neurons from trigeminal subnucleus caudalis: A population approach. Exp Neurol 293, 124–136 [DOI] [PubMed] [Google Scholar]
- 109.Bernard JF et al. (1995) Organization of the efferent projections from the spinal cervical enlargement to the parabrachial area and periaqueductal gray: A PHA-L study in the rat. J Comp Neurol 353, 480–505 [DOI] [PubMed] [Google Scholar]
- 110.Bourgeais L. et al. (2001) Parabrachial internal lateral neurons convey nociceptive messages from the deep laminas of the dorsal horn to the intralaminar thalamus. J Neurosci 21, 2159–65. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Beitz AJ et al. (1987) The nuclei of origin of brainstem enkephalin and cholecystokinin projections to the spinal trigeminal nucleus of the rat. Neuroscience 20, 409–25 [DOI] [PubMed] [Google Scholar]
- 112.Roeder Z. et al. (2016) The parabrachial complex links pain transmission to descending pain modulation. Pain 157, 2697–2708 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113.Verner TA et al. (2008) Retrograde projections to a discrete apneic site in the midline medulla oblongata of the rat. Brain Res 1208, 128–136 [DOI] [PubMed] [Google Scholar]
- 114.Chen Q and Heinricher MM (2019) Plasticity in the link between pain-transmitting and pain-modulating systems in acute and persistent inflammation. J Neurosci 39, 2065–2079 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115.Chaouch A. et al. (1983) Neurons at the origin of the medial component of the bulbopontine spinoreticular tract in the rat: An anatomical study using horseradish peroxidase retrograde transport. J Comp Neurol 214, 309–20 [DOI] [PubMed] [Google Scholar]
- 116.De Preter CC and Heinricher MM (2023) Direct and indirect nociceptive input from the trigeminal dorsal horn to pain-modulating neurons in the rostral ventromedial medulla. J Neurosci 43, 5779–5791 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 117.Gu X. et al. (2023) Neurons in the caudal ventrolateral medulla mediate descending pain control. Nat Neurosci 26, 594–605 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118.Cleary DR et al. (2008) Are opioid-sensitive neurons in the rostral ventromedial medulla inhibitory interneurons? Neuroscience 151, 564–71 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119.Heinricher MM and McGaraughty S (1998) Analysis of excitatory amino acid transmission within the rostral ventromedial medulla: Implications for circuitry. Pain 75, 247–255 [DOI] [PubMed] [Google Scholar]
- 120.Heinricher MM et al. (1991) Evidence for GABA-mediated control of putative nociceptive modulating neurons in the rostral ventromedial medulla: Iontophoresis of bicuculline eliminates the off-cell pause. Somatosens Mot Res 8, 215–25 [DOI] [PubMed] [Google Scholar]
- 121.Silva C and McNaughton N (2019) Are periaqueductal gray and dorsal raphe the foundation of appetitive and aversive control? A comprehensive review. Prog Neurobiol 177, 33–72 [DOI] [PubMed] [Google Scholar]
- 122.Keay KA and Bandler R (2001) Parallel circuits mediating distinct emotional coping reactions to different types of stress. Neurosci Biobehav Rev 25, 669–78 [DOI] [PubMed] [Google Scholar]
- 123.Koutsikou S. et al. (2015) The periaqueductal gray orchestrates sensory and motor circuits at multiple levels of the neuraxis. J Neurosci 35, 14132–47 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 124.Barbaro NM (1988) Studies of PAG/PVG stimulation for pain relief in humans. Prog. Brain Res 77, 165–173 [DOI] [PubMed] [Google Scholar]
- 125.Hosobuchi Y. et al. (1977) Pain relief by electrical stimulation of the central gray matter in humans and its reversal by naloxone. Science 197, 183–186 [DOI] [PubMed] [Google Scholar]
- 126.Richardson DE and Akil H (1977) Pain reduction by electrical brain stimulation in man. Part 1: Acute administration in periaqueductal and periventricular sites. J Neurosurg 47, 178–83 [DOI] [PubMed] [Google Scholar]
- 127.Mayer DJ et al. (1971) Analgesia from electrical stimulation in the brainstem of the rat. Science 174, 1351–4. [DOI] [PubMed] [Google Scholar]
- 128.Morgan MM et al. (1989) Stimulation of the periaqueductal gray matter inhibits nociception at the supraspinal as well as spinal level. Brain Res 502, 61–6 [DOI] [PubMed] [Google Scholar]
- 129.Samineni VK et al. (2017) Divergent modulation of nociception by glutamatergic and GABAergic neuronal subpopulations in the periaqueductal gray. eNeuro 4, ENEURO.0129-16.201 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 130.Assareh N. et al. (2023) Bidirectional modulation of nociception by GlyT2+ neurons in the ventrolateral periaqueductal gray. eNeuro 10, ENEURO.0069-23.2023 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 131.Drake RA et al. (2016) Periaqueductal grey ep3 receptors facilitate spinal nociception in arthritic secondary hypersensitivity. J Neurosci 36, 9026–40 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 132.McPherson KB and Ingram SL (2022) Cellular and circuit diversity determines the impact of endogenous opioids in the descending pain modulatory pathway. Front Syst Neurosci 16, 963812. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 133.Samineni VK et al. (2019) Cell type-specific modulation of sensory and affective components of itch in the periaqueductal gray. Nat Commun 10, 4356. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 134.Xie L. et al. (2023) Divergent modulation of pain and anxiety by GABAergic neurons in the ventrolateral periaqueductal gray and dorsal raphe. Neuropsychopharmacology 48, 1509–1519 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 135.Morgan MM et al. (2008) Periaqueductal gray neurons project to spinally projecting GABAergic neurons in the rostral ventromedial medulla. Pain 140, 376–386 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 136.Reichling DB and Basbaum AI (1990) Contribution of brainstem GABAergic circuitry to descending antinociceptive controls: II. Electron microscopic immunocytochemical evidence of GABAergic control over the projection from the periaqueductal gray to the nucleus raphe magnus in the rat. J Comp Neurol 302, 378–93 [DOI] [PubMed] [Google Scholar]
- 137.Kalyuzhny AE and Wessendorf MW (1998) Relationship of μ- and δ-opioid receptors to GABAergic neurons in the central nervous system, including antinociceptive brainstem circuits. J Comp Neurol 392, 528–47 [PubMed] [Google Scholar]
- 138.Lau BK and Vaughan CW (2014) Descending modulation of pain: The GABA disinhibition hypothesis of analgesia. Curr Opin Neurobiol 29C, 159–164 [DOI] [PubMed] [Google Scholar]
- 139.Osborne PB et al. (1996) Opioid inhibition of rat periaqueductal grey neurones with identified projections to rostral ventromedial medulla in vitro. J Physiol (Lond) 490, 383–9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 140.Kalyuzhny AE et al. (1996) μ -Opioid and δ-opioid receptors are expressed in brainstem antinociceptive circuits: Studies using immunocytochemistry and retrograde tract-tracing. J Neurosci 16, 6490–503 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 141.Du Y. et al. (2022) The contributions of mu-opioid receptors on glutamatergic and GABAergic neurons to analgesia induced by various stress intensities. eNeuro 9, ENEURO.0487-21.2022 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 142.Hardy SG (1985) Analgesia elicited by prefrontal stimulation. Brain Res 339, 281–4 [DOI] [PubMed] [Google Scholar]
- 143.Drake RA et al. (2021) Loss of cortical control over the descending pain modulatory system determines the development of the neuropathic pain state in rats. Elife 10, e65156. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 144.Cheriyan J and Sheets PL (2018) Altered excitability and local connectivity of mPFC-PAG neurons in a mouse model of neuropathic pain. J Neurosci 38, 4829–4839 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 145.Cheriyan J and Sheets PL (2020) Peripheral nerve injury reduces the excitation-inhibition balance of basolateral amygdala inputs to prelimbic pyramidal neurons projecting to the periaqueductal gray. Mol Brain 13, 100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 146.Huang J. et al. (2019) A neuronal circuit for activating descending modulation of neuropathic pain. Nat Neurosci 22, 1659–1668 [DOI] [PubMed] [Google Scholar]
- 147.Tran H. et al. (2024) Descending mechanism by which medial prefrontal cortex endocannabinoid signaling controls the development of neuropathic pain and neuronal activity of dorsal root ganglion. Pain 165, 102–114 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 148.Chen T. et al. (2018) Top-down descending facilitation of spinal sensory excitatory transmission from the anterior cingulate cortex. Nat Commun 9, 1886. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 149.Navratilova E. et al. (2015) Endogenous opioid activity in the anterior cingulate cortex is required for relief of pain. J Neurosci 35, 7264–71 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 150.Mason P and Fields HL (1989) Axonal trajectories and terminations of on- and off-cells in the cat lower brainstem. J Comp Neurol 288, 185–207 [DOI] [PubMed] [Google Scholar]
- 151.Yuste R. (2015) From the neuron doctrine to neural networks. Nat Rev Neurosci 16, 487–97 [DOI] [PubMed] [Google Scholar]
- 152.Melzack R and Katz J (2013) Pain. Wiley Interdiscip Rev Cogn Sci 4, 1–15 [DOI] [PubMed] [Google Scholar]
- 153.Chen Q. et al. (2017) Optogenetic evidence for a direct circuit linking nociceptive transmission through the parabrachial complex with pain-modulating neurons of the rostral ventromedial medulla (RVM). eNeuro 4, ENEURO.0202-17.2017 [DOI] [PMC free article] [PubMed] [Google Scholar]




